Molecular imaging theranostics of neuroendocrine tumors
E Fortunati, N Bonazzi, L Zanoni, S Fanti… - Seminars in Nuclear …, 2023 - Elsevier
Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …
Nuclear medicine application of pentixafor/pentixather targeting CXCR4 for imaging and therapy in related disease
Z Chen, Q Xue, S Yao - Mini Reviews in Medicinal Chemistry, 2023 - ingentaconnect.com
CXC-motif chemokine receptor 4 (CXCR4) is a novel predictive biomarker for metastasis
and poor prognosis in individuals with malignancies. CXCL12 is the only cognate ligand of …
and poor prognosis in individuals with malignancies. CXCL12 is the only cognate ligand of …
[HTML][HTML] Impact of CXCR4-directed PET/CT on staging and proposed oncologic management in patients with digestive system tumors
A Weich, SE Serfling, W Schlötelburg… - Clinical nuclear …, 2023 - journals.lww.com
Purpose To elucidate the influence of CXC motif chemokine receptor 4 (CXCR4)–directed
imaging on staging and proposed oncologic management in patients with digestive system …
imaging on staging and proposed oncologic management in patients with digestive system …
[HTML][HTML] Interobserver agreement rates on CXC Motif chemokine receptor 4–directed molecular imaging and therapy
PE Hartrampf, A Kosmala, SE Serfling… - Clinical nuclear …, 2023 - journals.lww.com
Background We aimed to evaluate the interobserver agreement rates in patients scanned
with CXC motif chemokine receptor 4 (CXCR4)–directed PET/CT, including the rate of …
with CXC motif chemokine receptor 4 (CXCR4)–directed PET/CT, including the rate of …
Case Study# 5: CXCR4-Targeted Radiotherapeutics
Radiopharmaceutical therapy (RPT) has become a mainstay of modern oncology but
remains limited to solid tumors, including orphan diseases such as neuroendocrine …
remains limited to solid tumors, including orphan diseases such as neuroendocrine …
Primäre und sekundäre Lebertumore–aus Sicht der Nuklearmedizin
A Holzgreve, H Ilhan, LM Unterrainer… - Angewandte …, 2023 - thieme-connect.com
Konventionelle, radiologische Modalitäten wie die Ultraschalldiagnostik, CT-und MRT-
Bildgebung sind der klinische Standard in der onkologischen Bildgebung primärer und …
Bildgebung sind der klinische Standard in der onkologischen Bildgebung primärer und …
Molecular Imaging in Oncology
S Vallabhajosula - Molecular Imaging and Targeted Therapy …, 2023 - Springer
Radioisotope-based molecular imaging (MI) techniques such as PET/CT and SPECT/CT
aim to integrate patient-specific and disease-specific molecular information with traditional …
aim to integrate patient-specific and disease-specific molecular information with traditional …
Theranostics in Neuroendocrine Tumors
S Vallabhajosula - Molecular Imaging and Targeted Therapy …, 2023 - Springer
Neuroendocrine neoplasms (NENs) are a heterogeneous group of epithelial neoplastic
proliferations ranging from indolent well differentiated neuroendocrine tumors (NETs) to very …
proliferations ranging from indolent well differentiated neuroendocrine tumors (NETs) to very …
Updated Review and Advances: Nuclear Medicine Study Evaluation of Neuroendocrine Tumors
E Dietsche, J Halpern… - Advances in …, 2023 - advancesinclinicalradiology.com
Neuroendocrine neoplasms (NENs) are a relatively uncommon but diverse group of
epithelial neoplasms, which can occur in almost any organ. They may be further categorized …
epithelial neoplasms, which can occur in almost any organ. They may be further categorized …